Back

Hypertrophic cardiomyopathy increases the risks of bradyarrhythmia and pacemaker implantation: a nationwide cohort study

30 August 2025 (10:15 - 11:00)
Organised by: Logo
Congress Presentation Part of: Improving outcome prediction in hypertrophic cardiomyopathy Hypertrophic Cardiomyopathy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Yu-Cheng Hsieh

Taichung Veterans General Hospital, Taichung (Taiwan)

7 More presentations in this session

Presentation thumbnail
Sudden cardiac death HCM risk scores in apical hypertrophic cardiomyopathy: an unmet need in clinical practice
Doctor A. Bello (Carnaxide, PT)
Abstract Slides Video
Presentation thumbnail
Cardiac magnetic resonance-derived left atrial global longitudinal strain identifies low-risk patients with hypertrophic cardiomyopathy
Doctor A. Subira Ingla (Barcelona, ES)
Abstract Slides Video
Presentation thumbnail
Bi-ventricular cardiovascular magnetic resonance strain phenotypes are predictive of cardiovascular outcomes in patients with asymptomatic hypertrophic cardiomyopathy
Ms S. Sajjad (Calgary, CA)
Abstract Slides Video
Presentation thumbnail
Longitudinal changes of left ventricular geometry and relationship with cardiac outcomes in patients with hypertrophic cardiomyopathy
Doctor T. Yoshitake (Fukuoka, JP)
Abstract Slides Video
Presentation thumbnail
Assessment of syncope and long-term outcome in patients diagnosed with hypertrophic cardiomyopathy, a propensity score matching analysis
Doctor C. Fumagalli (Naples, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Improving outcome prediction in hypertrophic cardiomyopathy

The Event

Event poster

ESC Congress 2025

30 August 2025 10:15 CET
You may be interested in
thumbnail
Congress Presentation
Contemporary outcomes of patients with hypertrophic cardiomyopathy and atrial fibrillation: a nationwide matched cohort study
thumbnail
Congress Presentation
Comparisons in cardiovascular outcomes and mortality in patients diagnosed with hypertrophic cardiomyopathy
thumbnail
Congress Presentation
Long-term efficacy and safety of ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources